Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND AIMS: The impairment of intestinal epithelial barrier is the main etiologic factor of inflammatory bowel disease. The proper intestinal epithelial proliferation and differentiation is crucial for maintaining intestinal integrity. Metformin is a common anti-diabetic drug. The objective is to evaluate the protective effects of metformin on ileal epithelial barrier integrity using interleukin-10 deficient (IL10KO) mice. METHODS: Wild-type and IL10KO mice were fed with/without metformin for 6 weeks and then ileum was collected for analyses. The mediatory role of AMP-activated protein kinase (AMPK) was further examined by gain and loss of function study in vitro. RESULTS: Compared to wild-type mice, IL10KO mice had increased proliferation, reduced goblet cell and Paneth cell lineage differentiation in the ileum tissue, which was accompanied with increased crypt expansion. Metformin supplementation mitigated intestinal cell proliferation, restored villus/crypt ratio, increased goblet cell and Paneth cell differentiation and improved barrier function. In addition, metformin supplementation in IL10KO mice suppressed macrophage pro-inflammatory activity as indicated by reduced M1 macrophage abundance and decreased pro-inflammatory cytokine IL-1β, TNF-α and IFN-γ expressions. As a target of metformin, AMPK phosphorylation was enhanced in mice treated with metformin, regardless of mouse genotypes. In correlation, the mRNA level of differentiation regulator including bmp4, bmpr2 and math1 were also increased in IL10KO mice supplemented with metformin, which likely explains the enhanced epithelial differentiation in IL10KO mice with metformin. Consistently, in Caco-2 cells, metformin promoted claudin-3 and E-cadherin assembly and mitigated TNF-α-induced fragmentation of tight junction proteins. Gain and loss of function assay also demonstrated AMPK was correlated with epithelial differentiation and proliferation. CONCLUSIONS: Metformin supplementation promotes secretory cell lineage differentiation, suppresses inflammation and improves epithelial barrier function in IL10KO mice likely through activation of AMPK, showing its beneficial effects on gut epithelial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A direct effect of metformin on the ileal epithelial barrier was also observed and the authors associated this improvement to increased activation of AMPK [305].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [305]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C.-H., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,696
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
Peterson, L. W., & Artis, D. (2014) · Nature Reviews Immunology · doi:10.1038/nri3608 · Cited by 3,173
Cytokines in inflammatory bowel disease
Neurath, M. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3661 · Cited by 2,706
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200
Intestinal homeostasis and its breakdown in inflammatory bowel disease
Maloy, K. J., & Powrie, F. (2011) · Nature · doi:10.1038/nature10208 · Cited by 1,870
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Johansson, M. E. V., Larsson, J. M. H., & Hansson, G. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006451107 · Cited by 1,452
Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress
Kim, Y. S., & Ho, S. B. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0131-2 · Cited by 1,435
Cited by
Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
Role of Goblet Cells in Intestinal Barrier and Mucosal Immunity
Yang, S., & Yu, M. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s318327 · Cited by 325
AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression
Sun, X., Yang, Q., Rogers, C. J., Du, M., & Zhu, M.-J. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.14 · Cited by 232
“Using IL-10 KO mice, we found that metformin supplementation improved intestinal epithelial barrier function associated with enhanced AMPK activation in ileum.(26) Therefore, AMPK exhibits crucial roles in mitigating IBD, and metabolic disorders-induced bowel dysfunctions, which might be partially caused by abnormal i…”
BackgroundSelf-citationTight junctions: from molecules to gastrointestinal diseases
Moonwiriyakit, A., Pathomthongtaweechai, N., Steinhagen, P., Chantawichitwong, P., Satianrapapong, W., & Pongkorpsakol, P. (2022) · Tissue Barriers · doi:10.1080/21688370.2022.2077620 · Cited by 185
“In mice orally administered metformin, the metformin delayed the onset of fructose-induced liver stenosis through reduced fructose function, in which alterations of MMPs and TIMP-1 concentrations in the intestine occurred.(297) Apart from being an antidiabetic drug, metformin was found to effectively benefit gut epith…”
BackgroundDeng, J., Zeng, L., Lai, X., Li, J., Liu, L., Lin, Q., & Chen, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13342 · Cited by 134
“A recent study reported that metformin treatment increased goblet cell differentiation and improved barrier function in IL-10KO mice [37].”
BackgroundOrchestration of MUC2 — The key regulatory target of gut barrier and homeostasis: A review
Liu, Y., Yu, Z., Zhu, L., Ma, S., Luo, Y., Liang, H., Liu, Q., Chen, J., Guli, S., & Chen, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.123862 · Cited by 127
Nguyen, H. D., Aljamaei, H. M., & Stadnyk, A. W. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.07.005 · Cited by 108
Metformin Protects against LPS-Induced Intestinal Barrier Dysfunction by Activating AMPK Pathway
Wu, W.-C., Wang, S., Liu, Q., Shan, T., & Wang, Y. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00332 · Cited by 107
Gabandé‐Rodríguez, E., Heras, M. M. G. D. L., & Mittelbrunn, M. (2019) · Cells · doi:10.3390/cells9010082 · Cited by 106
The Role and Mechanism of Metformin in Inflammatory Diseases
Lin, H., Ao, H., Guo, G., & Liu, M. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s436147 · Cited by 105
“138 It has similarly been shown in ApoE −/− mice as an atherosclerosis model.”
BackgroundKe, H., Li, F., Deng, W., Li, Z., Wang, S., Lv, P., & Chen, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.726707 · Cited by 101
“showed that metformin treatment increased the number of goblet cells by promoting secretory cell lineage differentiation, and reduced colonic inflammation via AMPK activation in IL10-knockout mice (Xue et al., 2016).”
BackgroundAla, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 95
Is metformin poised for a second career as an antimicrobial?
Malik, F. R., Mehdi, S. F., Ali, H., Patel, P., Basharat, A., Kumar, A., Ashok, F., Stein, J., Brima, W., Malhotra, P., et al. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2975 · Cited by 95
Tseng, C. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa136 · Cited by 89
Sahoo, D., Swanson, L., Sayed, I. M., Katkar, G. D., Ibeawuchi, S.-R., Mittal, Y., Pranadinata, R. F., Tindle, C., Fuller, M., Stec, D. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24470-5 · Cited by 88
“AMPK ’ s role (or the role of its agonists) in protecting the gut barrier has been evaluated in several murine models of colitis, including DSS 44 , TNBS 53 – 55 , IL10 − / − 56,57 and adoptive T-cell transfer models 58 .”
AMPK in regulation of apical junctions and barrier function of intestinal epithelium
Zhu, M. J., Sun, X., & Du, . (2018) · Tissue Barriers · doi:10.1080/21688370.2018.1487249 · Cited by 82
“Metformin supplementation decreases intestinal permeability, stimulates AMPK phosphorylation, and induces differentiation of goblet cells and Paneth cells in IL-10-deficient mice via AMPK-mediated BMP signaling pathway.(73) Inflammation impairs epithelial barrier function.”
BackgroundInfluentialSelf-citationAMPK Activation Promotes Tight Junction Assembly in Intestinal Epithelial Caco-2 Cells
Olivier, S., Leclerc, J., Grenier, A., Foretz, M., Tamburini, J., & Viollet, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205171 · Cited by 73
“Some studies using mouse models that mimic inflammatory bowel diseases showed a correlation between the decrease in intestinal AMPK activity and colitis development [16], and that metformin, an indirect AMPK activator, can protect against epithelial injuries [17,18].”
BackgroundAMP-activated protein kinase: a therapeutic target in intestinal diseases
Sun, X., & Zhu, M. J. (2017) · Open Biology · doi:10.1098/rsob.170104 · Cited by 73
“AMPK VilCre KO mice demonstrate exacerbated dextran sodium sulfate (DSS)-induced colitis [19], while metformin administration reduces colitis in interleukin-10-deficient mice [67] as well as DSS-induced colitis in mice [21].”
BackgroundSelf-citationMetformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation
Fusco, D. D., Dinallo, V., Monteleone, I., Laudisi, F., Marafini, I., Franzè, E., Grazia, A. D., Dwairi, R., Colantoni, A., Ortenzi, A., et al. (2018) · Clinical Science · doi:10.1042/cs20180167 · Cited by 71
Roles of AMP-Activated Protein Kinase (AMPK) in Mammalian Reproduction
Yang, W., Wang, L., Wang, F., & Yuan, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.593005 · Cited by 68
Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
Metformin effect on gut microbiota: insights for HIV-related inflammation
Ouyang, J., Isnard, S., Lin, J., Fombuena, B., Marette, A., Routy, B., Chen, Y., & Routy, J.-P. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00267-2 · Cited by 58
Wang, L., Qi, L., Gao, W., & Yu, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119914 · Cited by 48
Kumar, K. P., Ooi, J. D., & Goldberg, R. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1291724 · Cited by 46
Yang-Jensen, S. K., Nägele, N. S., & Jensen, B. A. H. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00704.2025 · Cited by 47
TLR2 Plays a Pivotal Role in Mediating Mucosal Serotonin Production in the Gut
Wang, H., Kwon, Y. H., Dewan, V., Vahedi, F., Syed, S. A., Fontes, M. E., Ashkar, A. A., Surette, M. G., & Khan, W. I. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801034 · Cited by 44
“Relative quantitative RT-PCR amplification was performed using SsoFast EvaGreen Supermix (Bio-Rad Laboratories) with the following primers at a concentration of 10 mM, and the cycling conditions used were previously described: mouse Tph1 (forward: 59-CAC GAG TGC AAG CCA AGG TTT-39; reverse: 59-AGT TTC CAG CCC CGA CAT…”
MethodLiu, Z., Liao, W., Zhang, Z., Sun, R., Luo, Y., Chen, Q., Li, X., Lu, R., & Ying, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.640347 · Cited by 43
Direct Action of Non-Digestible Oligosaccharides against a Leaky Gut
Mavrogeni, M. E., Asadpoor, M., Henricks, P. A. J., Keshavarzian, A., Folkerts, G., & Braber, S. (2022) · Nutrients · doi:10.3390/nu14214699 · Cited by 38
Ghosh, P., Swanson, L., Sayed, I. M., Mittal, Y., Lim, B. B. C., Ibeawuchi, S., Foretz, M., Viollet, B., Sahoo, D., & Das, S. (2020) · Life Science Alliance · doi:10.26508/lsa.201900481 · Cited by 35
“…and cancers (Yacyshyn et al, 1996; Barbara, 2006; Camilleri & Gorman, 2007; Sandek et al, 2007, 2008, 2012;Alametal,2014;Bischoffetal,2014;Nourietal,2014;Samsam et al, 2014; van De Sande et al, 2014; Clairembault et al, 2015; Lee et al, 2015; Buscarinu et al, 2016; Xue et al, 2016; Ghosh, 2017).”
Wanchaitanawong, W., Thinrungroj, N., Chattipakorn, S. C., Chattipakorn, N., & Shinlapawittayatorn, K. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109230 · Cited by 34
The emerging role of AMP-activated protein kinase in cholestatic liver diseases
Li, X., Liu, R., Zhang, L., & Jiang, Z. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.002 · Cited by 34
Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
Wiernsperger, N. F., Al‐Salameh, A., Cariou, B., & Lalau, J. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101359 · Cited by 32
“mental myocarditis [30], sepsis [31], gut inflammation [32], interleukin (IL)-10 deficient mice [33], lipopolysaccharide (LPS)-stimulated”
Tian, Q., Xu, Z., Sun, Q., Iniguez, A. B., Du, ., & Zhu, M. J. (2022) · Antioxidants · doi:10.3390/antiox11122404 · Cited by 25
“Metformin, an indirect AMPK activator, improves ileal epithelial barrier function in IL-10 knockout mice [55] and rescues intestinal barrier dysfunction induced by lipopolysaccharide [56].”
BackgroundSelf-citationTsukita, K., Yano, T., Tamura, A., & Tsukita, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236012 · Cited by 25
“By improving intestinal epithelial barrier dysfunction, metformin-induced activation of AMPK can alleviate inflammatory bowel disease in mouse models induced by interleukin-10 deficiency, dextran sulfate sodium, and heat stress [84,85,124].”
BackgroundSun, Q., Iniguez, A. B., Tian, Q., Du, ., & Zhu, M. J. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300446 · Cited by 23
Self-citationLi, Y., Yang, T., Yao, Q., Li, S., Fang, E., Li, Y., Liu, C., & Li, W.-M. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13556 · Cited by 23
Uddin, J., Sharma, A., Wu, D. X.-Y., Tomar, S., Ganesan, V., Reichel, P. E., Thota, L. N., Cabrera-Silva, R. I., Marella, S., Idelman, G., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.172978 · Cited by 23
α-Ketoglutarate for Preventing and Managing Intestinal Epithelial Dysfunction
Iniguez, A. B., Du, ., & Zhu, M. J. (2024) · Advances in Nutrition · doi:10.1016/j.advnut.2024.100200 · Cited by 21
“The importance of IL-10 is further exhibited by IL-10 de fi cient mice, which spontaneously develop colitis and exhibit lower RNA and protein levels of tight junction proteins [128,129].”
BackgroundSelf-citationPetrov, J. C., Desai, A., Kochhar, G. S., Crosby, S. K., Kinnucan, J. A. R., Picco, M. F., Hashash, J. G., & Farraye, F. A. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae147 · Cited by 18
Wu, Z., Xu, C., Zheng, T., Li, Q., Yang, S., Shao, J., Guan, W., & Zhang, S. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30841 · Cited by 18
“Low levels of α‐defensin and β‐defensin due to reduced numbers of Paneth cells can be upregulated by metformin in a mouse model (Xue et al., 2016).”
BackgroundInfluentialActivation of P2Y1R impedes intestinal mucosa repair during colitis
Huan, Q., Jiao, P., Chang, Y., Zhang, Q., Xing, T., Jiang, D., Chen, W., Shen, X., Bian, Z., & Xiao, H. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.82302 · Cited by 13
“In addition, several lines of evidence suggest that pharmacological, nutritional, and physiological activation of AMPK can strengthen epithelial apical junctions and protect the epithelial barrier from environmental stress or injury [36-39], suggesting that AMPK activation ensures better recovery of epithelial barrier…”
BackgroundIniguez, A. B., Tian, Q., Du, ., & Zhu, M. J. (2022) · Nutrients · doi:10.3390/nu14061148 · Cited by 13
“gov/ij/, accessed on 6 June 2021) for ratio of goblet cells/overall area [26].”
BackgroundSelf-citationYogurt starter strains ameliorate intestinal barrier dysfunction via activating AMPK in Caco-2 cells
KOBAYASHI, K., Mochizuki, J., Yamazaki, F., & Sashihara, T. (2023) · Tissue Barriers · doi:10.1080/21688370.2023.2184157 · Cited by 13
Berkowitz, L., Pardo‐Roa, C., Ramírez, G., Vallejos, O. P., Sebastián, V. P., Riedel, C. A., Álvarez-Lobos, M., & Bueno, S. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221618 · Cited by 13
Panaro, M. A., Budriesi, R., Calvello, R., Cianciulli, A., Mattioli, L., Corazza, I., Rotondo, N. P., Porro, C., Lamonaca, A., Ferraro, V., et al. (2024) · Nutrients · doi:10.3390/nu16193327 · Cited by 12
Binsaleh, A. Y., El-Haggar, S. M., Hegazy, S. K., Maher, M., Bahgat, M. M., El-Masry, T. A., Alrubia, S., Alsegiani, A. S., Eldesoqui, M. B., & Bahaa, M. M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1507009 · Cited by 12
The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults
Ghosh, P. (2017) · Aging · doi:10.18632/aging.101179 · Cited by 12
“, may affect a variety of diseases that are associated with increased intestinal permeability (reviewed in [51]) such as critical illness, inflammatory bowel diseases [52, 53], celiac disease, food allergy, irritable bowel syndrome [54, 55], Alzheimer’s [56], Parkinson’s [57], multiple sclerosis [58-60], autism [61, 6…”
BackgroundLai, F., Chen, Y., Lin, H.-M., Wang, X., Zhu, X., Li, Y., Xiao, H., & Cao, X. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.05.021 · Cited by 12
Céspedes, N., Donnelly, E. L., Hansten, G., Fellows, A. M., Dobson, M. E., Kaylor, H. L., Coles, T. A., Schauer, J. D., de Water, J. V., & Luckhart, S. (2024) · Infection and Immunity · doi:10.1128/iai.00360-23 · Cited by 11
“Others have suggested that IL-10 helps to maintain barrier integrity by modulating intercellular junctions and promoting cell repair (77, 78), promoting Paneth cell and goblet cell development and function (79), regulating apoptosis (80, 81), and modulating the inflammatory response by limiting the…”
BackgroundSun, Q., Bibi, S., Xue, Y., Du, ., Chew, B. P., & Zhu, M. J. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109585 · Cited by 9
Self-citationHuang, Y., Lin, J., Chen, W., Shia, B., & Wu, S. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf165 · Cited by 8
AMPK Deficiency Increases DNA Methylation and Aggravates Colorectal Tumorigenesis in AOM/DSS Mice
Sun, Q., Tian, Q., Iniguez, A. B., Sun, X., Zhang, H., de Avila, J. M., Du, ., & Zhu, M. J. (2024) · Genes · doi:10.3390/genes15070835 · Cited by 8
“The immunohistochemical staining was performed as described previously with modifications [30,31].”
MethodSelf-citationInfection by Leishmania (Leishmania) infantum chagasi causes intestinal changes B‐1 cells dependent
Souza, K. D., Fernandes, E. P. A., dos Santos, A. G. A., de Lima, L. L., Gonzaga, W. F. K. M., Xander, P. B., de Melo, G. D. A. N., & Sant’Ana, D. D. M. G. (2019) · Parasite Immunology · doi:10.1111/pim.12661 · Cited by 8
KOBAYASHI, K., Imai, Y., Shimizu, Y., Ogawa, I., Nakai, T., Mizuno, Y., Kaneda, Y., Watanabe‐Yasuoka, Y., Yamazaki, F., Mochizuki, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1585007 · Cited by 6
“Metformin (33), an AMPK activator, and food materials (34, 35) increase TJ expression in Caco-2 cells.”
Buğdaycı, A. Y., Dizakar, S. Ö. A., Demirel, M. A., Ömeroğlu, S., Akar, F., & Uludağ, M. O. (2024) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-024-00521-2 · Cited by 5
Molavi, M., Amin, B., & Sahebkar, M. (2025) · Internal and Emergency Medicine · doi:10.1007/s11739-025-04222-9 · Cited by 4
Hu, Y., Chen, Z., Zhou, M.-H., Zhao, Z., Wang, X., Huang, J., Li, X., & Zeng, J.-N. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1375915 · Cited by 4
Bahaa, M. M., Abdallah, M. S., Mosalam, E. M., Gardouh, A. R., Nazih, M., Hamza, E., Al-Dhelaan, R. A., & Kamal, N. (2026) · Inflammopharmacology · doi:10.1007/s10787-025-02101-5 · Cited by 2
Paneth Cells Are a Constitutive Source of IL-10 in Mouse Small Intestinal Organoids
Nguyen, H. D., Cara, F. D., Wang, J., & Stadnyk, A. W. (2025) · Organoids · doi:10.3390/organoids4010004 · Cited by 1
“Although reduced LYZ1 expression was not observed in vivo, the packing of lysozyme granules in Paneth cells of IL-10KO mice were reported to be abnormal compared to Paneth cells in WT mice [14,28,29].”
Li, Y., Xingqi, G., Dong, X., Xia, T., Ma, S., & Liu, Z. (2026) · iScience · doi:10.1016/j.isci.2026.114877 · Cited by 1
“141,145 In line with in vitro findings, metformin could reduce gut epithelial permeability in IBD mouse models 145,146 but showed diminished efficacy in mucosal healing stages.”
Koohshekan, B., Minaiyan, M., Hashemnia, M., & Aarabi, M. H. (2025) · Research in Pharmaceutical Sciences · doi:10.4103/rps.rps_121_24 · Cited by 1
“MTF supplementation enhanced goblet cell differentiation and improved the function of the epithelial barrier in IL-10-deficient (IL10KO) mice (12) and alleviated UC in mice through alterations in microbiota structure (13).”
Metformin improves endotoxemia and alters folliculogenesis in women with polycystic ovary syndrome
Trzcinski, M., Chudzicka-Strugała, I., Kim, K. K., Piekarski, P., Spaczyński, R., Zwoździak, B., Banaszewska, B., Pawelczyk, L. A., Chang, R. J., & Dulęba, A. J. (2026) · Endocrine Connections · doi:10.1530/ec-26-0120 · Cited by 1
“It is likely that the reduction in LPSs and LBP by metformin may be due, at least in part, to previously demonstrated effects on gut permeability (22, 23) or alterations of the gut microbiome (24, 25).”
Regulation of Claudin-3 Expression in Kidney Tubular Epithelial Cells
Anwer, S. (2020) · TSpace (University of Toronto) · Cited by 1
Kollar, L. B. (2017) · Gutenberg Open Science · doi:10.25358/openscience-1388 · Cited by 1
The Regulatory Mechanisms of PIR-B and STARD7 in Inflammatory Bowel Disease
Uddin, J. (2022) · Deep Blue (University of Michigan) · doi:10.7302/4602
Wu, T., Horowitz, M., Jones, K. L., & Rayner, C. K. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102276
“…slowing of gastric emptying [16,17], enhancing secretion and/or signalling of the incretin hormone, glucagon-like peptide-1 (GLP-1) [16 — 20], inhibiting intestinal glucose absorption [21 — 25], and modulating bile acid signalling [26,27], the gut microbiota [28], and epithelial integrity [29].”
Shivkumar, A. (2024) · eScholarship (California Digital Library)
Ke, H., Li, F., Deng, W., Li, Z., Wang, S., Lv, P., & Chen, Y. (2021) · doi:10.3389/fphar.2021.726707.s001
Metadata
- Authors
- Xue, Y., Zhang, H., Sun, X., & Zhu, M.-J.
- Affiliations
- University of Idaho (US)
- Washington State University (US)
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2016-12-21
- Volume
- 11
- Issue
- 12
- Pages
- e0168670
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5176295
- OpenAlex
- W2565774918
- Cited by
- 61
- References
- 68
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 10 · 2023: 5 · 2022: 7 · 2021: 7 · 2020: 5 · 2019: 8 · 2018: 3 · 2017: 7
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (R15HD073864)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, intestinal epithelial barrier, interleukin-10 deficiency, AMPK, goblet cell differentiation, Paneth cell differentiation, intestinal epithelial cell proliferation, macrophage polarization, tight junction proteins, BMP signaling, inflammatory bowel disease
- MeSH terms
- Animals, Cell Differentiation, Humans, Intestinal Mucosa, Macrophages, Metformin, Mice, Inbred C57BL, Permeability, Phosphorylation, Tumor Necrosis Factor-alpha, Cadherins, Cytokines, Interleukin-10, Mice, Knockout, Caco-2 Cells, Goblet Cells, Mice, Basic Helix-Loop-Helix Proteins, Bone Morphogenetic Protein Receptors, Type II, AMP-Activated Protein Kinases, Bone Morphogenetic Protein 4, Claudin-3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.